查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1905148

日本败血症诊断市场报告（按诊断、产品、检测方式、技术、病原体、最终用户和地区划分，2026-2034年）

Japan Sepsis Diagnostics Market Report by Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本脓毒症诊断市场规模达2,580万美元。展望未来， IMARC Group预计到2034年，该市场规模将达到4,890万美元，2026年至2034年间的复合年增长率（CAGR）为7.36%。推动市场成长的主要因素是先进资料分析工具的日益普及，这些工具通常能够整合来自不同平台的多项检测结果，从而提供即时资料存取和精准的疾病诊断。

本报告解答的关键问题

  • 1.日本败血症诊断市场规模有多大？
  • 2.日本败血症诊断市场前景如何？
  • 3.哪些因素正在推动日本脓毒症诊断市场的成长？

目录

第一章：序言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 数据来源
  • 市场估算
  • 预测方法

第三章：执行概要

第四章：日本脓毒症诊断市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本败血症诊断市场概况

  • 历史及当前市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本败血症诊断市场－依诊断类型划分

  • 自动化诊断
  • 传统诊断

第七章：日本败血症诊断市场－依产品细分

  • 仪器
  • 检测试剂盒和试剂
  • 血液培养基
  • 软体

第八章：日本脓毒症诊断市场－依检测方式划分

  • 实验室检测
  • 即时检测

第九章：日本脓毒症诊断市场－依技术划分

  • 分子诊断
  • 免疫测定
  • 生物标誌物
  • 流式细胞仪
  • 微流控技术
  • 血液培养

第十章：日本脓毒症诊断市场－按病原体划分

  • 细菌性败血症
  • 病毒性败血症
  • 霉菌性败血症
  • 其他的

第十一章：日本脓毒症诊断市场－以最终用户划分

  • 诊断诊所
  • 医院
  • 研究实验室

第十二章：日本脓毒症诊断市场－按地区划分

  • 关东地区
  • 关西/近畿地区
  • 中部/中部地区
  • 九州·冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十三章：日本败血症诊断市场－竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争格局分析
  • 公司评估象限

第十四章：关键参与者简介

第十五章：日本脓毒症诊断市场－产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十六章：附录

简介目录
Product Code: SR112026A18716

Japan sepsis diagnostics market size reached USD 25.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 48.9 Million by 2034, exhibiting a growth rate (CAGR) of 7.36% during 2026-2034. The increasing adoption of advanced data analytics tools that generally enable the integration of multiple test results from different platforms to offer real-time data access and accurate disease diagnosis is primarily driving the market growth.

Sepsis is a medical condition that arises as a response of the body when it attempts to combat infections caused by the presence of bacteria, viruses, or fungi. In this state, the immune system releases various chemicals into the bloodstream, setting off excessive inflammation and the formation of blood clots throughout the body. Sepsis can lead to the failure of multiple organs, irregular breathing, low blood pressure, neurological dysfunction, an elevated heart rate, and more. The diagnostic methods for detecting sepsis primarily encompass molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, and similar technologies. These diagnostic techniques see widespread use in various healthcare settings, including hospitals, pathology laboratories, reference laboratories, and academic research institutions, among others.

Japan Sepsis Diagnostics Market Trends:

In the Japanese market, the surge in demand for sepsis diagnostics can be attributed to several key factors. Firstly, there is a noticeable increase in hospital-acquired infections (HAIs) that can lead to sepsis, particularly among vulnerable demographic groups such as the elderly, infants, and patients with chronic ailments. This trend is a driving force behind the need for improved sepsis diagnostic tools. Secondly, the growing instances of infectious diseases caused by antibiotic-resistant bacteria, including both gram-positive bacteria and gram-negative bacilli, are contributing to the heightened demand for sepsis diagnostics in Japan. These antibiotic-resistant strains require accurate and timely diagnosis for effective treatment. Furthermore, Japan's expanding healthcare sector, coupled with the widespread adoption of advanced data analytics tools, is playing a significant role in catalyzing the growth of the sepsis diagnostics market. These tools enable the integration of diverse test results from various platforms, offering real-time access to critical data and precise disease diagnosis. Additionally, continuous technological advancements have led to the development of new immunological and molecular biomarkers, facilitating early sepsis detection. Investment in extensive research and development activities, including innovative blood culture methods for identifying and managing chronic infections, is expected to contribute to the expansion of the sepsis diagnostics market in Japan over the forecasted period.

Japan Sepsis Diagnostics Market Segmentation:

Diagnosis Insights:

  • Automated Diagnostics
  • Conventional Diagnostics

Product Insights:

  • Instruments
  • Assay Kits and Reagents
  • Blood Culture Media
  • Software

Mode of Testing Insights:

  • Laboratory Tests
  • Point-of-Care Tests

Technology Insights:

  • Molecular Diagnostics
  • Immunoassays
  • Biomarkers
  • Flow Cytometry
  • Microfluidics
  • Blood Culture

Pathogen Insights:

  • Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
    • Gram-Negative Bacterial Sepsis
  • Viral Sepsis
  • Fungal Sepsis
  • Others

End User Insights:

  • Diagnostic Clinics
  • Hospitals
  • Research Laboratories

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report

  • 1.How big is the sepsis diagnostics market in Japan?
  • 2.What is the forecast for the sepsis diagnostics market in Japan?
  • 3.What factors are driving the growth of the Japan sepsis diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Sepsis Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Sepsis Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Sepsis Diagnostics Market - Breakup by Diagnosis

  • 6.1 Automated Diagnostics
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Conventional Diagnostics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)

7 Japan Sepsis Diagnostics Market - Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Assay Kits and Reagents
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Blood Culture Media
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Software
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)

8 Japan Sepsis Diagnostics Market - Breakup by Mode of Testing

  • 8.1 Laboratory Tests
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Point-of-Care Tests
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Sepsis Diagnostics Market - Breakup by Technology

  • 9.1 Molecular Diagnostics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Immunoassays
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Biomarkers
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Flow Cytometry
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Forecast (2026-2034)
  • 9.5 Microfluidics
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Forecast (2026-2034)
  • 9.6 Blood Culture
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Forecast (2026-2034)

10 Japan Sepsis Diagnostics Market - Breakup by Pathogen

  • 10.1 Bacterial Sepsis
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Segmentation
      • 10.1.3.1 Gram-Positive Bacterial Sepsis
      • 10.1.3.2 Gram-Negative Bacterial Sepsis
    • 10.1.4 Market Forecast (2026-2034)
  • 10.2 Viral Sepsis
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Fungal Sepsis
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Forecast (2026-2034)
  • 10.4 Others
    • 10.4.1 Historical and Current Market Trends (2020-2025)
    • 10.4.2 Market Forecast (2026-2034)

11 Japan Sepsis Diagnostics Market - Breakup by End User

  • 11.1 Diagnostic Clinics
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Forecast (2026-2034)
  • 11.2 Hospitals
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Forecast (2026-2034)
  • 11.3 Research Laboratories
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Forecast (2026-2034)

12 Japan Sepsis Diagnostics Market - Breakup by Region

  • 12.1 Kanto Region
    • 12.1.1 Overview
    • 12.1.2 Historical and Current Market Trends (2020-2025)
    • 12.1.3 Market Breakup by Diagnosis
    • 12.1.4 Market Breakup by Product
    • 12.1.5 Market Breakup by Mode of Testing
    • 12.1.6 Market Breakup by Technology
    • 12.1.7 Market Breakup by Pathogen
    • 12.1.8 Market Breakup by End User
    • 12.1.9 Key Players
    • 12.1.10 Market Forecast (2026-2034)
  • 12.2 Kansai/Kinki Region
    • 12.2.1 Overview
    • 12.2.2 Historical and Current Market Trends (2020-2025)
    • 12.2.3 Market Breakup by Diagnosis
    • 12.2.4 Market Breakup by Product
    • 12.2.5 Market Breakup by Mode of Testing
    • 12.2.6 Market Breakup by Technology
    • 12.2.7 Market Breakup by Pathogen
    • 12.2.8 Market Breakup by End User
    • 12.2.9 Key Players
    • 12.2.10 Market Forecast (2026-2034)
  • 12.3 Central/ Chubu Region
    • 12.3.1 Overview
    • 12.3.2 Historical and Current Market Trends (2020-2025)
    • 12.3.3 Market Breakup by Diagnosis
    • 12.3.4 Market Breakup by Product
    • 12.3.5 Market Breakup by Mode of Testing
    • 12.3.6 Market Breakup by Technology
    • 12.3.7 Market Breakup by Pathogen
    • 12.3.8 Market Breakup by End User
    • 12.3.9 Key Players
    • 12.3.10 Market Forecast (2026-2034)
  • 12.4 Kyushu-Okinawa Region
    • 12.4.1 Overview
    • 12.4.2 Historical and Current Market Trends (2020-2025)
    • 12.4.3 Market Breakup by Diagnosis
    • 12.4.4 Market Breakup by Product
    • 12.4.5 Market Breakup by Mode of Testing
    • 12.4.6 Market Breakup by Technology
    • 12.4.7 Market Breakup by Pathogen
    • 12.4.8 Market Breakup by End User
    • 12.4.9 Key Players
    • 12.4.10 Market Forecast (2026-2034)
  • 12.5 Tohoku Region
    • 12.5.1 Overview
    • 12.5.2 Historical and Current Market Trends (2020-2025)
    • 12.5.3 Market Breakup by Diagnosis
    • 12.5.4 Market Breakup by Product
    • 12.5.5 Market Breakup by Mode of Testing
    • 12.5.6 Market Breakup by Technology
    • 12.5.7 Market Breakup by Pathogen
    • 12.5.8 Market Breakup by End User
    • 12.5.9 Key Players
    • 12.5.10 Market Forecast (2026-2034)
  • 12.6 Chugoku Region
    • 12.6.1 Overview
    • 12.6.2 Historical and Current Market Trends (2020-2025)
    • 12.6.3 Market Breakup by Diagnosis
    • 12.6.4 Market Breakup by Product
    • 12.6.5 Market Breakup by Mode of Testing
    • 12.6.6 Market Breakup by Technology
    • 12.6.7 Market Breakup by Pathogen
    • 12.6.8 Market Breakup by End User
    • 12.6.9 Key Players
    • 12.6.10 Market Forecast (2026-2034)
  • 12.7 Hokkaido Region
    • 12.7.1 Overview
    • 12.7.2 Historical and Current Market Trends (2020-2025)
    • 12.7.3 Market Breakup by Diagnosis
    • 12.7.4 Market Breakup by Product
    • 12.7.5 Market Breakup by Mode of Testing
    • 12.7.6 Market Breakup by Technology
    • 12.7.7 Market Breakup by Pathogen
    • 12.7.8 Market Breakup by End User
    • 12.7.9 Key Players
    • 12.7.10 Market Forecast (2026-2034)
  • 12.8 Shikoku Region
    • 12.8.1 Overview
    • 12.8.2 Historical and Current Market Trends (2020-2025)
    • 12.8.3 Market Breakup by Diagnosis
    • 12.8.4 Market Breakup by Product
    • 12.8.5 Market Breakup by Mode of Testing
    • 12.8.6 Market Breakup by Technology
    • 12.8.7 Market Breakup by Pathogen
    • 12.8.8 Market Breakup by End User
    • 12.8.9 Key Players
    • 12.8.10 Market Forecast (2026-2034)

13 Japan Sepsis Diagnostics Market - Competitive Landscape

  • 13.1 Overview
  • 13.2 Market Structure
  • 13.3 Market Player Positioning
  • 13.4 Top Winning Strategies
  • 13.5 Competitive Dashboard
  • 13.6 Company Evaluation Quadrant

14 Profiles of Key Players

  • 14.1 Company A
    • 14.1.1 Business Overview
    • 14.1.2 Services Offered
    • 14.1.3 Business Strategies
    • 14.1.4 SWOT Analysis
    • 14.1.5 Major News and Events
  • 14.2 Company B
    • 14.2.1 Business Overview
    • 14.2.2 Services Offered
    • 14.2.3 Business Strategies
    • 14.2.4 SWOT Analysis
    • 14.2.5 Major News and Events
  • 14.3 Company C
    • 14.3.1 Business Overview
    • 14.3.2 Services Offered
    • 14.3.3 Business Strategies
    • 14.3.4 SWOT Analysis
    • 14.3.5 Major News and Events
  • 14.4 Company D
    • 14.4.1 Business Overview
    • 14.4.2 Services Offered
    • 14.4.3 Business Strategies
    • 14.4.4 SWOT Analysis
    • 14.4.5 Major News and Events
  • 14.5 Company E
    • 14.5.1 Business Overview
    • 14.5.2 Services Offered
    • 14.5.3 Business Strategies
    • 14.5.4 SWOT Analysis
    • 14.5.5 Major News and Events

15 Japan Sepsis Diagnostics Market - Industry Analysis

  • 15.1 Drivers, Restraints, and Opportunities
    • 15.1.1 Overview
    • 15.1.2 Drivers
    • 15.1.3 Restraints
    • 15.1.4 Opportunities
  • 15.2 Porters Five Forces Analysis
    • 15.2.1 Overview
    • 15.2.2 Bargaining Power of Buyers
    • 15.2.3 Bargaining Power of Suppliers
    • 15.2.4 Degree of Competition
    • 15.2.5 Threat of New Entrants
    • 15.2.6 Threat of Substitutes
  • 15.3 Value Chain Analysis

16 Appendix